Literature DB >> 15786721

Effects of single high-dose and multiple low-dose streptozotocin on contraction and intracellular Ca2+ in ventricular myocytes from diabetes resistant and susceptible rats.

F C Howarth1, A Qureshi, A Shahin, M L Lukic.   

Abstract

Administration of a single high-dose (SHD) of streptozotocin (STZ) to young adult rats causes a diabetic cardiomyopathy. Albino Oxford (AO) and Dark Agouti (DA) inbred strains of rats are susceptible to developing diabetes when administered a SHD of STZ but differ in susceptibility to multiple low-dose (MLD) STZ. We have investigated the effects of SHD and MLD-STZ on contraction and intracellular Ca2+, measured with fura-2, in ventricular myocytes from AO and DA rats at 18-20 weeks after treatment. Time to peak shortening was significantly prolonged in myocytes from DA rats after SHD-STZ but was not altered in DA rats after MLD-STZ or in AO rats by either MLD or SHZ-STZ treatment. Time to peak shortening in myocytes from DA control and DA rats after SHD-STZ were 88+/-2 ms and 107+/-4 ms, respectively. Time to half relaxation and the amplitude of myocyte shortening were not altered in AO or DA rats by either MLD or SHD-STZ treatment. Amplitude, time to peak fura-2 transient and time to half relaxation of the fura-2 transient were not significantly altered in AO or DA rats by either MLD or SHD-STZ treatment. Contractile defects reported in myocytes from SHD-STZ treated DA rats may be a consequence of altered myofilament sensitivity to Ca2+. The hyperglycaemic effects of MLD-STZ and SHD-STZ induced diabetes was much greater in DA compared to AO rats and the effects of the hyperglycaemia on the time-course of ventricular myocyte contraction was most profound in DA rats after SHD-STZ.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15786721     DOI: 10.1007/s11010-005-3088-y

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  15 in total

1.  The rising global burden of diabetes and its complications: estimates and projections to the year 2010.

Authors:  A F Amos; D J McCarty; P Zimmet
Journal:  Diabet Med       Date:  1997       Impact factor: 4.359

2.  The effects of mechanical loading and changes of length on single guinea-pig ventricular myocytes.

Authors:  E White; M R Boyett; C H Orchard
Journal:  J Physiol       Date:  1995-01-01       Impact factor: 5.182

3.  Antidiabetogenic effect of pentoxifylline is associated with systemic and target tissue modulation of cytokines and nitric oxide production.

Authors:  S Stosić-Grujicić; D Maksimović; V Badovinac; T Samardzić; V Trajković; M Lukić; M Mostarica Stojković
Journal:  J Autoimmun       Date:  2001-02       Impact factor: 7.094

4.  Alterations in contractile properties and Ca2+ handling in streptozotocin-induced diabetic rat myocardium.

Authors:  T Ishikawa; H Kajiwara; S Kurihara
Journal:  Am J Physiol       Date:  1999-12

5.  Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats.

Authors:  Kin M Choi; Yan Zhong; Brian D Hoit; Ingrid L Grupp; Harvey Hahn; Keith W Dilly; Silvia Guatimosim; W Jonathan Lederer; Mohammed A Matlib
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06-27       Impact factor: 4.733

6.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

7.  Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody.

Authors:  K C Herold; J A Bluestone; A G Montag; A Parihar; A Wiegner; R E Gress; R Hirsch
Journal:  Diabetes       Date:  1992-03       Impact factor: 9.461

8.  Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice.

Authors:  M L Lukic; S Stosic-Grujicic; N Ostojic; W L Chan; F Y Liew
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

9.  Abnormalities of K+ and Ca2+ currents in ventricular myocytes from rats with chronic diabetes.

Authors:  D W Wang; T Kiyosue; S Shigematsu; M Arita
Journal:  Am J Physiol       Date:  1995-10

Review 10.  Effector mechanisms in low-dose streptozotocin-induced diabetes.

Authors:  M L Lukić; S Stosić-Grujicić; A Shahin
Journal:  Dev Immunol       Date:  1998
View more
  4 in total

1.  The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model.

Authors:  Ming Zhang; Xiao-Yan Lv; Jing Li; Zhi-Gang Xu; Li Chen
Journal:  Exp Diabetes Res       Date:  2009-01-04

2.  Streptozotocin, type I diabetes severity and bone.

Authors:  Katherine Motyl; Laura R McCabe
Journal:  Biol Proced Online       Date:  2009-03-06       Impact factor: 3.244

Review 3.  A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes.

Authors:  Emily J Cox; Susan A Marsh
Journal:  PLoS One       Date:  2014-03-24       Impact factor: 3.240

4.  Pathogenesis of Type 1 Diabetes Mellitus and Rodent Experimental Models.

Authors:  I G Gvazava; O S Rogovaya; M A Borisov; E A Vorotelyak; A V Vasiliev
Journal:  Acta Naturae       Date:  2018 Jan-Mar       Impact factor: 1.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.